These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 16203029

  • 1. Iron chelators deferoxamine and diethylenetriamine pentaacetic acid induce apoptosis in ovarian carcinoma.
    Brard L, Granai CO, Swamy N.
    Gynecol Oncol; 2006 Jan; 100(1):116-27. PubMed ID: 16203029
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
    Chaston TB, Lovejoy DB, Watts RN, Richardson DR.
    Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
    [Abstract] [Full Text] [Related]

  • 4. Suppression of human ovarian SKOV-3 cancer cell growth by Duchesnea phenolic fraction is associated with cell cycle arrest and apoptosis.
    Peng B, Chang Q, Wang L, Hu Q, Wang Y, Tang J, Liu X.
    Gynecol Oncol; 2008 Jan; 108(1):173-81. PubMed ID: 17959232
    [Abstract] [Full Text] [Related]

  • 5. A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells.
    Petrucci E, Pasquini L, Petronelli A, Saulle E, Mariani G, Riccioni R, Biffoni M, Ferretti G, Benedetti-Panici P, Cognetti F, Scambia G, Humphreys R, Peschle C, Testa U.
    Gynecol Oncol; 2007 May; 105(2):481-92. PubMed ID: 17292950
    [Abstract] [Full Text] [Related]

  • 6. Apoptosis during iron chelator-induced differentiation in F9 embryonal carcinoma cells.
    Tanaka T, Satoh T, Onozawa Y, Kohroki J, Itoh N, Ishidate M, Muto N, Tanaka K.
    Cell Biol Int; 1999 May; 23(8):541-50. PubMed ID: 10704238
    [Abstract] [Full Text] [Related]

  • 7. Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo.
    Jiang XP, Wang F, Yang DC, Elliott RL, Head JF.
    Anticancer Res; 2002 May; 22(5):2685-92. PubMed ID: 12529982
    [Abstract] [Full Text] [Related]

  • 8. Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle.
    Brodie C, Siriwardana G, Lucas J, Schleicher R, Terada N, Szepesi A, Gelfand E, Seligman P.
    Cancer Res; 1993 Sep 01; 53(17):3968-75. PubMed ID: 8358725
    [Abstract] [Full Text] [Related]

  • 9. Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis.
    Takai N, Kawamata N, Gui D, Said JW, Miyakawa I, Koeffler HP.
    Cancer; 2004 Dec 15; 101(12):2760-70. PubMed ID: 15536623
    [Abstract] [Full Text] [Related]

  • 10. The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamine.
    Gharagozloo M, Khoshdel Z, Amirghofran Z.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):1-7. PubMed ID: 18619590
    [Abstract] [Full Text] [Related]

  • 11. Cell cycle synchronization and growth inhibition by 3-hydroxypyridin-4-one iron chelators in leukemia cell lines.
    Hoyes KP, Hider RC, Porter JB.
    Cancer Res; 1992 Sep 01; 52(17):4591-9. PubMed ID: 1511427
    [Abstract] [Full Text] [Related]

  • 12. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell.
    Richardson D, Ponka P, Baker E.
    Cancer Res; 1994 Feb 01; 54(3):685-9. PubMed ID: 8306330
    [Abstract] [Full Text] [Related]

  • 13. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Int J Mol Med; 2006 Feb 01; 17(2):323-9. PubMed ID: 16391833
    [Abstract] [Full Text] [Related]

  • 14. A small molecule compound inhibits AKT pathway in ovarian cancer cell lines.
    Tang HJ, Jin X, Wang S, Yang D, Cao Y, Chen J, Gossett DR, Lin J.
    Gynecol Oncol; 2006 Feb 01; 100(2):308-17. PubMed ID: 16209885
    [Abstract] [Full Text] [Related]

  • 15. Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo.
    Fister S, Günthert AR, Emons G, Gründker C.
    Cancer Res; 2007 Feb 15; 67(4):1750-6. PubMed ID: 17308117
    [Abstract] [Full Text] [Related]

  • 16. Growth inhibitory effect of D-allose on human ovarian carcinoma cells in vitro.
    Sui L, Dong Y, Watanabe Y, Yamaguchi F, Hatano N, Izumori K, Tokuda M.
    Anticancer Res; 2005 Feb 15; 25(4):2639-44. PubMed ID: 16080505
    [Abstract] [Full Text] [Related]

  • 17. Anti-tumor activities of four chelating agents against human neuroblastoma cells.
    Shen L, Zhao HY, Du J, Wang F.
    In Vivo; 2005 Feb 15; 19(1):233-6. PubMed ID: 15796180
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
    Fan L, Iyer J, Zhu S, Frick KK, Wada RK, Eskenazi AE, Berg PE, Ikegaki N, Kennett RH, Frantz CN.
    Cancer Res; 2001 Feb 01; 61(3):1073-9. PubMed ID: 11221835
    [Abstract] [Full Text] [Related]

  • 19. Arsenic Trioxide inhibits the growth of human ovarian carcinoma cell line.
    Bornstein J, Sagi S, Haj A, Harroch J, Fares F.
    Gynecol Oncol; 2005 Dec 01; 99(3):726-9. PubMed ID: 16243384
    [Abstract] [Full Text] [Related]

  • 20. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Int J Mol Med; 2008 May 01; 21(5):637-43. PubMed ID: 18425357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.